M. Factor

A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia

M. Strupp, G. Churchill, F. Platt, 2021, Trials.

A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia

M. Strupp, A. Galione, G. Churchill, 2020, Trials.

Acetylation turns leucine into a drug by membrane transporter switching

M. Strupp, A. Galione, G. Churchill, 2021, Scientific Reports.

Acetylation of L-leucine switches its carrier from the L-amino acid transporter (LAT) to organic anion transporters (OAT)

M. Strupp, A. Galione, G. Churchill, 2020, bioRxiv.

N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study

A. Galione, T. Fields, I. Billington, 2023, Trials.

Update on the Global Campaign Against Terrorist Financing: Second Report of an Independent Task Force on Terrorist Financing

Maurice R. Greenberg, William F. Wechsler, Lee S. Wolosky, 2004 .